Mycio Wealth Partners LLC lowered its position in UnitedHealth Group Inc. (NYSE:UNH) by 2.5% during the third quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 10,287 shares of the healthcare conglomerate’s stock after selling 259 shares during the period. Mycio Wealth Partners LLC’s holdings in UnitedHealth Group were worth $1,440,000 as of its most recent SEC filing.
Other institutional investors have also modified their holdings of the company. Daiwa SB Investments Ltd. acquired a new position in shares of UnitedHealth Group during the second quarter worth about $6,183,000. Washington Trust Bank increased its position in shares of UnitedHealth Group by 0.4% in the second quarter. Washington Trust Bank now owns 29,319 shares of the healthcare conglomerate’s stock worth $4,140,000 after buying an additional 109 shares in the last quarter. NEXT Financial Group Inc increased its position in shares of UnitedHealth Group by 22.7% in the second quarter. NEXT Financial Group Inc now owns 2,252 shares of the healthcare conglomerate’s stock worth $317,000 after buying an additional 416 shares in the last quarter. Osborn Rohs Williams & Donohoe Ltd increased its position in shares of UnitedHealth Group by 0.4% in the second quarter. Osborn Rohs Williams & Donohoe Ltd now owns 8,984 shares of the healthcare conglomerate’s stock worth $1,269,000 after buying an additional 33 shares in the last quarter. Finally, Park National Corp OH increased its position in shares of UnitedHealth Group by 2.4% in the second quarter. Park National Corp OH now owns 9,211 shares of the healthcare conglomerate’s stock worth $1,301,000 after buying an additional 216 shares in the last quarter. Institutional investors own 86.04% of the company’s stock.
Shares of UnitedHealth Group Inc. (NYSE:UNH) traded down 0.48% during mid-day trading on Friday, reaching $152.81. The company’s stock had a trading volume of 1,664,542 shares. The firm has a 50-day moving average of $142.75 and a 200-day moving average of $139.46. The firm has a market capitalization of $145.45 billion, a PE ratio of 22.57 and a beta of 0.63. UnitedHealth Group Inc. has a 52 week low of $107.51 and a 52 week high of $154.50.
UnitedHealth Group (NYSE:UNH) last issued its quarterly earnings results on Tuesday, October 18th. The healthcare conglomerate reported $2.17 earnings per share for the quarter, topping analysts’ consensus estimates of $2.08 by $0.09. UnitedHealth Group had a return on equity of 19.92% and a net margin of 3.62%. The company had revenue of $46.30 billion for the quarter, compared to analyst estimates of $46.09 billion. During the same quarter in the prior year, the company posted $1.77 EPS. The business’s revenue for the quarter was up 11.6% compared to the same quarter last year. Equities research analysts forecast that UnitedHealth Group Inc. will post $8.01 earnings per share for the current fiscal year.
The firm also recently declared a quarterly dividend, which will be paid on Tuesday, December 13th. Shareholders of record on Friday, December 2nd will be paid a dividend of $0.625 per share. This represents a $2.50 dividend on an annualized basis and a dividend yield of 1.64%. The ex-dividend date of this dividend is Wednesday, November 30th. UnitedHealth Group’s dividend payout ratio is presently 36.93%.
Several research firms have recently weighed in on UNH. Vetr upgraded UnitedHealth Group from a “buy” rating to a “buy” rating in a research report on Friday, October 7th. Jefferies Group restated a “buy” rating and issued a $163.00 target price on shares of UnitedHealth Group in a research report on Tuesday, October 4th. Leerink Swann restated an “outperform” rating on shares of UnitedHealth Group in a research report on Sunday, August 21st. Cowen and Company set a $150.00 target price on UnitedHealth Group and gave the company a “buy” rating in a research report on Tuesday, September 6th. Finally, Evercore ISI began coverage on UnitedHealth Group in a research report on Thursday, September 22nd. They issued a “buy” rating and a $155.00 target price on the stock. Two research analysts have rated the stock with a hold rating and twenty-two have issued a buy rating to the stock. UnitedHealth Group presently has a consensus rating of “Buy” and an average target price of $158.03.
In other UnitedHealth Group news, EVP D Ellen Wilson sold 14,365 shares of the stock in a transaction on Friday, October 21st. The stock was sold at an average price of $144.18, for a total transaction of $2,071,145.70. Following the transaction, the executive vice president now owns 66,635 shares of the company’s stock, valued at approximately $9,607,434.30. The sale was disclosed in a filing with the SEC, which is available at the SEC website. Also, Director Richard T. Burke sold 40,000 shares of the stock in a transaction on Wednesday, September 7th. The stock was sold at an average price of $135.31, for a total value of $5,412,400.00. Following the transaction, the director now directly owns 2,003,550 shares in the company, valued at approximately $271,100,350.50. The disclosure for this sale can be found here. Company insiders own 1.65% of the company’s stock.
UnitedHealth Group Company Profile
UnitedHealth Group Incorporated is a diversified healthcare company. The Company operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight and OptumRx. The Company conducts its operations through two business platforms: health benefits operating under UnitedHealthcare and health services operating under Optum.